Research Article

Protective Role of UCP2 in Oxidative Stress and Apoptosis during the Silent Phase of an Experimental Model of Epilepsy Induced by Pilocarpine

Figure 4

Expression of hippocampal UCP2 and p-AKT in the presence or absence of antisense oligonucleotide (ASO) treatment in SE rats. (a) Treatment with ASO diminished UCP2 mRNA expression in rats 5 days after SE onset. versus control and 5 d ep ASO; versus 5 d ep; (b) UCP2 protein expression presented high levels 5 days after SE. ASO treatment successfully decreased UCP2 protein expression 5 days after SE. versus control; versus control and SE 5 d; (c) p-AKT expression diminished after ASO treatment. versus control; versus control and SE 5 d according to two-way ANOVA followed by Tukey’s post hoc tests. Values are means ± SEM.
(a)
(b)
(c)